Table 7 ER+/PR+ subgroup-specific differences in serum U6, 5S, and other RNAs
From: Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients
Column ID | Pvalue | Fold change |
|---|---|---|
Metastasis versus healthy | ||
   U6 | 0.0024 | 3.26 |
   U6-SNORD44 | 0.003 | 4.18 |
   miR-16 | 0.001 | 2.83 |
   miR-16-SNORD44 | 0.002 | 3.65 |
   5S | 0.0027 | -21 |
   5S-SNORD44 | 0.007 | -16 |
   SNORD44 | 0.275 | -1.3 |
Cancer-free versus healthy | ||
   U6 | 3.09 × 10-5 | 5.4 |
   U6-SNORD44 | 0.0002 | 6.35 |
   miR-16 | 0.004 | 2.46 |
   miR-16-SNORD44 | 0.01 | 2.9 |
   5S | 0.05 | -7.2 |
   5S-SNORD44 | 0.07 | -6.16 |
   SNORD44 | 0.51 | -1.17 |
Metastasis versus cancer-free | ||
   U6 | 0.16 | -1.68 |
   U6-SNORD44 | 0.37 | -1.51 |
   miR-16 | 0.64 | 1.14 |
   miR-16-SNORD44 | 0.55 | 1.27 |
   5S | 0.268 | -2.93 |
   5S-SNORD44 | 0.326 | -2.65 |
   SNORD44 | 0.66 | -1.11 |